A study demonstrates that GalNAc-Lipid nanoparticles can achieve efficient liver-targeted delivery of CRISPR base editing therapy, offering a potential option for treating familial hypercholesterolemia and other liver diseases. Key Highlights…

Key Preview: Unraveling the Research Questions In the realm of cancer therapeutics, a pivotal challenge remains: how to effectively deliver drugs to tumors that often possess tight endothelial barriers. The…

Key Preview: A Promising Solution for Precision Cancer Therapy Researchers have developed an innovative multifunctional bioresponsive and fluorescent-active nanogel designed for both breast cancer therapy and bioimaging. The study addresses…

Introduction: Navigating the Challenges of Inflammatory Bowel DiseaseInflammatory bowel diseases (IBDs), including ulcerative colitis (UC) and Crohn’s disease (CD), present persistent challenges due to their chronic nature and significant impact…

Introduction: A New Dawn for Light-Activated Drug DeliveryAdvancements in cancer therapy have witnessed a paradigm shift with the emergence of light-activated drug delivery systems, combining precision with minimized side effects.…

A study demonstrates that GalNAc-Lipid nanoparticles can achieve efficient liver-targeted delivery of CRISPR base editing therapy, offering a potential option for treating familial hypercholesterolemia and other liver diseases. Background Challenges…

A dissolving microneedle system incorporating dexamethasone-loaded nanoparticles has been developed to enhance therapeutic outcomes for inflammatory skin diseases by offering controlled drug delivery and improved patient compliance. Advances in Transdermal…

The convergence of polymer science and nanotechnology has spurred remarkable advancements in healthcare, enabling targeted, efficient, and multifunctional therapeutic strategies. Recent research reveals the versatile applications of polymeric nanoparticles across…